PET-CT Tracers in China and what each does to the price
A whole-body PET-CT in China using the standard tracer, fluorine-18 FDG, costs about ¥4,100–8,100 (roughly $600–1,200) as a self-pay international patient. Every other tracer is quoted per case and costs more. The reason is that the radioactive tracer, not the scanner, is the expensive part of a PET-CT — and the specialist tracers are manufactured in the hospital’s own radiopharmacy a couple of hours before your appointment. If you are booking a screening checkup, you want FDG and nothing else. If an oncologist has named PSMA, DOTATATE or NaF on a request letter, you are doing a different exercise, and this page is about that one.
The four tracers you are likely to be offered
| Tracer | What it is for | Where it comes from | Cost vs FDG |
|---|---|---|---|
| ¹⁸F-FDG fluorodeoxyglucose | General oncology and metabolic activity. The checkup and screening default. | Cyclotron; can be delivered from a regional supplier | ¥4,100–8,100 — the baseline |
| ¹⁸F-NaF sodium fluoride | Bone. Metastases, occult fracture, joint disease. | Same cyclotron as FDG | Small premium |
| ⁶⁸Ga-PSMA-11 gozetotide | Prostate cancer. Staging and biochemical recurrence. | Generator, eluted on site the same morning | Quoted per case, well above FDG |
| ⁶⁸Ga-DOTATATE | Neuroendocrine tumours, via somatostatin-receptor binding. | Generator, eluted on site the same morning | Quoted per case; often two scans |
Why the tracer, not the scanner, sets the price
Every PET tracer is decaying while you travel to it, and the half-life decides the entire economics of the scan.
Fluorine-18 has a half-life of about 110 minutes. That is long enough for one cyclotron production run to be divided among many patients and driven to hospitals within a two-to-three-hour radius. The considerable cost of making it is spread thin. This is why FDG has a published price band at all.
Gallium-68 has a half-life of about 68 minutes. It cannot be shipped anywhere. It is eluted from a germanium-68 generator standing in the hospital’s own radiopharmacy, and that generator yields a limited number of elutions per day and is replaced on a fixed schedule whether or not anybody uses it. A gallium-68 scan therefore carries a share of a large fixed capital cost spread across comparatively few patients. Reported figures put the ⁶⁸Ga-DOTATATE tracer dose alone above ¥5,000 — more than an entire FDG scan before the scanner is switched on.
Ask any quote for a specialist-tracer scan to state explicitly whether the tracer is inside the price. On a standard FDG scan the question barely matters. On a gallium-68 study the tracer can be the larger half of the bill, and a quote that omits it is not a quote.
Where China’s price advantage compresses
This is the part almost nobody budgets for correctly. China’s saving is largest where the cost is staff time and scanner time, and smallest where the cost is a globally priced consumable. A PET-CT is a mixture of both, and the mixture changes with the tracer.
FDG is manufactured domestically at scale, so an FDG PET-CT captures close to the full discount — which is why our PET-CT cost page can quote a saving in the 80% range against typical US pricing. Germanium-68 generators and the DOTATATE and PSMA precursor peptides are specialty products bought on the same world market that every other country buys from. The scanner time is still cheap; the vial is not.
So expect the headline saving to shrink on a gallium-68 study — still a real saving, but not the same one. If a quote implies an 80–90% discount on a PSMA or DOTATATE scan, that is worth a second look, because the underlying consumable does not get 80% cheaper by crossing a border. The same arithmetic applies to any procedure dominated by an imported device or drug rather than by theatre time.
⁶⁸Ga-PSMA is now a registered product, not a research scan
China’s National Medical Products Administration approved gallium-68 gozetotide — the registered name for ⁶⁸Ga-PSMA-11 — in 2025, alongside lutetium Lu 177 vipivotide tetraxetan, the corresponding therapy. That is a meaningful change for anyone travelling for a prostate-cancer scan.
Before it, PSMA PET in China was largely investigator-led work at a handful of academic centres, which meant fitting a research protocol and its eligibility criteria. As a registered product it is something a nuclear-medicine department can offer as ordinary care. Availability is still concentrated in large tertiary hospitals rather than spread evenly, so confirm with the specific centre before booking flights — but you are asking a scheduling question now, not an access question.
⁶⁸Ga-DOTATATE is frequently two scans, not one
For neuroendocrine tumours, Chinese practice commonly uses a two-day paired protocol: ⁶⁸Ga-DOTATATE on one day and ¹⁸F-FDG on the other. The two tracers answer different questions about the same tumour — DOTATATE shows somatostatin-receptor expression, FDG shows metabolic aggressiveness — and read together they describe a tumour neither shows alone.
If that is what your oncologist has requested, plan accordingly: two tracer charges, two scanner sessions, two days on the ground, and a report that may only be finalised after the second. Say “paired two-day protocol” when you request the quote so the hospital prices what you are actually having.
¹⁸F-NaF for bone: the smallest premium
Sodium fluoride is made on the same cyclotron that produces FDG, with no separate generator or supply chain, which is why it is the least expensive step away from the standard scan.
Against a conventional technetium-99m MDP bone scan — still the default in many hospitals — NaF PET images sooner after injection, produces markedly better image quality, includes a low-dose CT in the same session, and detects more lesions. If someone offers you a choice between the two, the price gap is usually smaller than people assume. It is a reasonable question to ask outright rather than to accept the default.
If this is a checkup, you want FDG
Screening and staging are different activities and the tracer choice follows from which one you are doing. A specialist tracer is built to bind one receptor found on one family of tumours; it is close to blind to everything else. Used for general screening it costs more and tells you less, and it will not reassure you about the things a checkup is meant to look at.
For the screening case — what a PET-CT is and is not good at, whether you need one at all, and what it costs — see PET-CT scan cost in China and cancer screening in China for foreigners. A great many people who ask about PET-CT for screening are better served by a targeted panel plus whole-body MRI, which uses no radiation at all.
How to get a real quote
Specialist-tracer scans are not bookable from a price list, so the request has to carry enough information for the hospital to price it. Send ahead:
- The requesting letter naming the tracer — the single thing that makes the request legible. Without it you will be quoted a standard FDG scan.
- Prior imaging and pathology, ideally as DICOM files rather than printed images, so the reading physician can compare rather than start over.
- Your date range, given early and given wide.
Then ask for four things in writing: whether the tracer is available on your dates, whether the tracer is inside the quoted price, whether it is a paired two-day protocol, and the report language and turnaround. On the last point, see getting your results in English — a nuclear-medicine report is exactly the kind of document your own oncologist will need to read verbatim, and taking the files home matters more here than for routine bloodwork.
Availability is a booking constraint, not only a price one
Because a generator yields a fixed number of doses on a production day, centres tend to batch gallium-68 patients onto particular weekdays rather than scanning on demand. The bottleneck is the radiopharmacy’s production calendar, not the scanner’s diary, which is often reasonably open.
Book weeks ahead. Treat a specialist-tracer slot offered at short notice as worth confirming twice — occasionally it is a genuine cancellation on an existing production day, and occasionally it is a scan that will be quietly rebooked after you have landed.
Common questions
Which PET-CT tracer do I need in China?
For a screening checkup, fluorine-18 FDG, and nothing else. FDG is a glucose analogue that shows metabolic activity anywhere in the body, which is what you want when you are not looking for one specific thing. The specialist tracers are the opposite: each is designed to bind one receptor found on one family of tumours, so ordering one without a specific clinical question costs more and tells you less. If an oncologist has already named a tracer on a request letter, that letter is the answer and the job is availability and scheduling rather than choice.
How much does a PET-CT with a specialist tracer cost in China?
A standard whole-body FDG PET-CT runs roughly 4,100 to 8,100 RMB for a self-pay international patient, and published municipal schedules sit inside that band, with Zhejiang setting 5,300 RMB per scan under its price reform. Gallium-68 studies are not published as a standard band anywhere and are quoted per case, meaningfully above the FDG figure. One reference point for why: the gallium-68 DOTATATE tracer dose alone has been reported above 5,000 RMB, which is more than an entire FDG scan before the scanner is switched on. Ask for the quote in writing and ask explicitly whether the tracer is inside it.
Why is gallium-68 so much more expensive than FDG?
Half-life. Fluorine-18 has a half-life of about 110 minutes, so one cyclotron production run can be split between many patients and driven to hospitals within a two to three hour radius; the cost of making it spreads across all of them. Gallium-68 has a half-life of about 68 minutes, which is too short to ship. It is eluted from a germanium-68 generator standing in the hospital's own radiopharmacy, and that generator yields a limited number of elutions per day and is replaced on a fixed schedule whether or not it is used. A gallium-68 scan therefore carries a share of a large fixed capital cost spread over comparatively few patients.
Is gallium-68 PSMA available in China?
Yes, and its status changed recently. China's NMPA approved gallium-68 gozetotide, the registered name for gallium-68 PSMA-11, in 2025, alongside lutetium Lu 177 vipivotide tetraxetan. In practice that moves PSMA PET from something a handful of academic centres ran under investigator-led protocols to a registered product a nuclear-medicine department can offer as routine care. For anyone travelling for a prostate-cancer scan it is the difference between needing to fit a research protocol and simply booking. Availability is still concentrated in large tertiary centres, so confirm with the specific hospital.
Can I get gallium-68 DOTATATE in China, and is it one scan or two?
It is available at major nuclear-medicine departments, and it is often not one scan. Chinese clinical practice for neuroendocrine tumours frequently uses a two-day paired protocol, gallium-68 DOTATATE on one day and fluorine-18 FDG on the other, because the two tracers answer different questions about the same tumour: receptor expression versus metabolic aggressiveness. If that is what your oncologist has requested, budget for two tracer charges, two scanner sessions and two days on the ground, and say so when you ask for a quote.
How much does 18F-NaF cost compared with FDG?
It carries the smallest premium of any specialist tracer, because sodium fluoride is made on the same cyclotron that produces FDG, so no separate generator or supply chain is involved. Against a conventional technetium-99m MDP bone scan it images sooner after injection, produces markedly better image quality, includes a low-dose CT in the same session and detects more lesions. If you are being offered a choice between a conventional bone scan and NaF PET, the price gap is usually smaller than people expect and worth asking about directly.
How far ahead should I book a specialist-tracer scan?
Weeks, not days, and for a different reason than usual. Because a generator yields a fixed number of doses per production day, centres tend to batch gallium-68 patients onto particular weekdays rather than scanning on demand. So the constraint is not the scanner's diary, which is often reasonably open, but the radiopharmacy's production calendar. Give the hospital your date range early and let them place you, and treat any date offered at short notice as worth confirming twice.
Does China's price advantage apply equally to every tracer?
No, and this is the most common budgeting mistake. China's saving is largest where the cost is staff time and scanner time, and smallest where the cost is a globally priced consumable. FDG is manufactured domestically at scale, so an FDG PET-CT captures the full discount. Germanium-68 generators and the DOTATATE and PSMA precursor peptides are specialty products bought into the same world market everyone else buys from, so the discount compresses. Expect a smaller percentage saving on a gallium-68 study than the figure quoted for a standard FDG scan.
Getting the right scan, not the most expensive one
The pattern we see most often is someone arriving convinced they need the most advanced tracer available, when the request letter in their bag says FDG. The tracer is a clinical decision that was already made by the doctor who ordered it. What is worth optimising is everything around it: the right centre, a date the radiopharmacy can actually serve, a report your own oncologist can read, and the files to go with it.